Monthly Slides 12–15 slides
GLP-1 & weight-loss drugs
Trial data, capacity and insurance coverage
[hot] Biotech & health · Monthly
AI drug discovery
AI-discovered candidates, clinical progress and deals
Sign in to Divrite to manage subscriptions.
About this briefing
Every issue of “AI drug discovery” is researched by Divrite from public sources and published as a written report of 4,000–6,000 words. Early each month, covering last month. Key figures come with a link to their source, and anything without a reliable source is left out.
- Schedule
- Monthly — Early each month, covering last month
- Format
- written report
- Length
- 4,000–6,000 words
- Time range
- Last 30 days
- Coverage
- Clinical progress of AI-discovered or designed drug candidates, pharma–AI deals, and protein and molecule model advances.
Every issue covers
- 01Key takeaways
- 02Pipeline progress
- 03Deals and partnerships
- 04Models and platforms
- 05Funding
- 06Regulatory discussion
Key sources
- ClinicalTrials.gov
- Company announcements
- Papers
- Industry databases
Past issues 1 published
Related topics
- Quarterly Report 4,000–6,000 words
Gene editing & cell therapy
Approvals and clinical progress for CRISPR, CAR-T and more
Follow “AI drug discovery”
Early each month, covering last month. Every issue is archived on this page. Subscribers get an in-app message and an email when a new issue is published.